Elevated YKL-40 levels are documented in patients having acute myocardial infarction (MI) [3]–[5], and are also associated with all-cause and cardiovascular mortality in patients with stable CAD [4] and in individuals representative of the general population [6], [7]. This evidence concerns the gene CHI3L1 and coronary artery disorder.